Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06036836
Title Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | NLD | ITA | FRA | DEU | CAN | AUS

Facility Status City State Zip Country Details
Yale-New Haven Hospital-Yale Cancer Center ( Site 0643) New Haven Connecticut 06510 United States Details
Dana-Farber Cancer Institute ( Site 0642) Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey ( Site 0635) New Brunswick New Jersey 08903 United States Details
Duke Cancer Institute ( Site 0641) Durham North Carolina 27710 United States Details
Cleveland Clinic Main ( Site 0639) Cleveland Ohio 44195 United States Details
St. Luke's University Health Network ( Site 0636) Bethlehem Pennsylvania 18015 United States Details
UPMC Hillman Cancer Center ( Site 0644) Pittsburgh Pennsylvania 15232 United States Details
UT Southwestern Medical Center-CRO-Simmons Comprehensive Cancer Center ( Site 0645) Dallas Texas 75390-9179 United States Details
St Vincent's Hospital-The Kinghorn Cancer Centre ( Site 0005) Darlinghurst New South Wales 2010 Australia Details
Royal North Shore Hospital ( Site 0008) St Leonards New South Wales 2065 Australia Details
Blacktown Hospital ( Site 0003) Sydney New South Wales 2148 Australia Details
Royal Brisbane and Women's Hospital ( Site 0002) Brisbane Queensland 4029 Australia Details
The Alfred Hospital ( Site 0004) Melbourne Victoria 3004 Australia Details
Fiona Stanley Hospital ( Site 0006) Murdock Western Australia 6150 Australia Details
Sunnybrook Research Institute ( Site 0607) Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Cancer Centre ( Site 0606) Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital ( Site 0605) Montreal Quebec H3T 1E2 Canada Details
Centre Hospitalier de l'Université de Montréal ( Site 0602) Montréal Quebec H2X 3E4 Canada Details
McGill University Health Centre ( Site 0604) Montréal Quebec H4A 3J1 Canada Details
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0 Quebec City Quebec G1J 1Z4 Canada Details
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0153) Strasbourg Alsace 67200 France Details
Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan ( Site 0154) Brest Finistere 29200 France Details
CENTRE LEON BERARD ( Site 0151) Lyon Cedex08 Rhone-Alpes 69373 France Details
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0155) Paris 75014 France Details
Universitaetsklinikum Essen ( Site 0185) Essen Nordrhein-Westfalen 45147 Germany Details
Universitaetsklinikum Essen-Klinik für Dermatologie, Venerologie und Allergologie ( Site 0182) Essen Nordrhein-Westfalen 45147 Germany Details
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Dermatologie ( Site 0183) Dresden Sachsen 01307 Germany Details
Fondazione IRCCS Istituto Nazionale dei Tumori-SC Oncologia Medica 3 - Tumori Testa-collo ( Site 025 Milan Lombardia 20133 Italy Details
Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapi Napoli 80131 Italy Details
Hospital Sultan Ismail-Pusat Rawatan Radioterapi Dan Onkologi ( Site 0063) Johor Bahru Johor 81100 Malaysia Details
University Malaya Medical Centre ( Site 0061) Lembah Pantai Kuala Lumpur 59100 Malaysia Details
Sarawak General Hospital-Radiotherapy Unit ( Site 0062) Kuching Sarawak 93586 Malaysia Details
Radboudumc ( Site 0274) Nijmegen Gelderland 6525 GA Netherlands Details
Erasmus Medisch Centrum ( Site 0272) Rotterdam Zuid-Holland 3015 GD Netherlands Details
University Medical Center Groningen ( Site 0273) Groningen 9713GZ Netherlands Details
Taichung Veterans General Hospital-GYNECOLOGY ( Site 0033) Taichung 407 Taiwan Details
National Cheng Kung University Hospital-Clinical Trial Center ( Site 0032) Tainan 704 Taiwan Details
National Taiwan University Hospital ( Site 0031) Taipei 10002 Taiwan Details
Medipol Mega Universite Hastanesi-oncology ( Site 0425) Stanbul Istanbul 34214 Turkey Details
Gulhane Egitim Arastirma Hastanesi-Onkoloji ( Site 0424) Ankara 06010 Turkey Details
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0421) Ankara 06230 Turkey Details
Liv Hospital Ankara-Oncology ( Site 0426) Ankara 06680 Turkey Details
Ankara Bilkent Şehir Hastanesi ( Site 0427) Ankara 06800 Turkey Details
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 0423) Istanbul 34722 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field